Steve Elms, Director, Ten Percent Owner at Loxo Oncology, holds 328.34K shares in Marker Therapeutics (Ticker: MRKR), holds 2.74M shares in Zosano Pharma (Ticker: ZSANQ), holds 2.04M shares in Loxo Oncology (Ticker: LOXO). Most recently, Steve Elms Bought ― shares of Marker Therapeutics on Dec 26, 2024 for an estimated value of 35.47K.
Steve Elms latest transaction was an Informative Buy of $35.47K.
What was Steve Elms's most profitable transaction?
Steve Elms’s most profitable transaction was an Informative Buy of LOXO stock on August 6, 2014. The return on the trade was 55.90%.
What is Steve Elms's role in Loxo Oncology?
Steve Elms's role in Loxo Oncology is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.